The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis)
Open accessAbstract
BACKGROUND: Neuralgic amyotrophy (also know as Parsonage-Turner syndrome or brachial plexus neuritis) is a distinct peripheral nervous system disorder characterised by episodes (attacks) of extreme neuropathic pain and rapid multifocal weakness and atrophy in the upper limbs. Neuralgic amyotrophy has both an idiopathic and hereditary form, with similar clinical symptoms but generally an earlier age of onset and more episodes in the hereditary form. The current hypothesis is that the episodes are caused by an immune-mediated response to the brachial plexus. Recovery is slow, in months to years, and many patients are left with residual pain and decreased exercise tolerance of the affected limb(s). Anecdotal evidence suggests that corticosteroids may relieve pain or help improve functional recovery. OBJECTIVES: The objective was to provide a systematic review of all randomised clinical trials of treatment in neuralgic amyotrophy. SEARCH STRATEGY: We searched the Cochrane Neuromuscular Disease Group Trials Register (April 2 2009), MEDLINE (January 1966 to April 2 2009), EMBASE (January 1980 to April 2 2009), CINAHL (January 1982 to April 2 2009), and LILACS (January 1982 to April 2 2009) for randomised controlled trials of treatment for neuralgic amyotrophy. SELECTION CRITERIA: Any randomised or quasi-randomised trial of any intervention for neuralgic amyotrophy would be included in the review. DATA COLLECTION AND ANALYSIS: Two review authors extracted the data (RH, NvA) and two authors assessed study quality and performed data extraction independently (NvA, BvE). MAIN RESULTS: No randomised or quasi-randomised trials were identified. In 30 articles anecdotal evidence was found on treatment for neuralgic amyotrophy. Only three of these articles contained more than 10 treated cases, with one providing sufficient details to calculate the primary and secondary outcome measures for this review. AUTHORS' CONCLUSIONS: At this moment there is no evidence from randomised trials on any form of treatment for neuralgic amyotrophy. Evidence from one open-label retrospective series suggests that oral prednisone given in the first month after onset can shorten the duration of the initial pain and leads to earlier recovery in some patients. Randomised clinical trials are needed to establish the efficacy of treatment with corticosteroids or other immune-modulating therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
MacDonald, B. K. (2000) · Brain · doi:10.1093/brain/123.4.665 · Cited by 858
Cited by
Neuralgic amyotrophy: An update on diagnosis, pathophysiology, and treatment
Van Eijk, J. J. J., Groothuis, J. T., & Van Alfen, N. (2016) · Muscle & Nerve · doi:10.1002/mus.25008 · Cited by 282
Self-citationClinical and pathophysiological concepts of neuralgic amyotrophy
van Alfen, N. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.62 · Cited by 269
Self-citation
Metadata
- Authors
- van Alfen, N., van Engelen, B. G., & Hughes, R. A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2009-07-08
- Issue
- 3
- Pages
- CD006976-CD006976
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2103349401
- Cited by
- 175
- References
- 2
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). https://app.cochat.ai/papers/10.1002/14651858.cd006976.pub2
- The paper
- van Alfen, N., van Engelen, B. G., & Hughes, R. A. (2009). Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd006976.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.